RW Investment Management’s Merck MRK Stock Holding History

RW Investment Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,570	Closed	-$207K	–	93
2024 Q1	$207K	Buy	+1,570	New	+$194K	0.03%	87

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RW Investment Management's MRK Position: Q2 2024 in Review

RW Investment Management sold out of Merck (MRK) in Q2 2024, closing a stake of 1,570 shares — an estimated $207K sold.

RW Investment Management first reported a position in MRK in Q1 2024 and held it in 1 quarter. The position peaked at $207K in Q1 2024. 3,545 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

RW Investment Management reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
RW Investment Management sold 1,570 Merck shares in Q2 2024, an estimated $207K.
RW Investment Management first reported a position in Merck in Q1 2024 and held it in 1 quarter.
RW Investment Management's Merck position peaked at $207K in Q1 2024.
3,545 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on RW Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.